Importance of receptor expression in the classification of novel ligands at the M 2 muscarinic acetylcholine receptor

Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs

(2022) Charlotte Avet et al.   eLife

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes

(2021) Stephen PH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors

(2021) Stephen PH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Fusion with Promiscuous Gα16 Subunit Reveals Signaling Bias at Muscarinic Receptors

(2021) Alena Randáková et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Novel M 2 ‐selective, G i ‐biased agonists of muscarinic acetylcholine receptors

(2020) Alena Randáková et al.   BRITISH JOURNAL OF PHARMACOLOGY

TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome

(2020) Reid H. J. Olsen et al.   Nature Chemical Biology

Analyzing kinetic signaling data for G-protein-coupled receptors

(2020) Sam R. J. Hoare et al.   Scientific Reports

Illuminating G-Protein-Coupling Selectivity of GPCRs

(2019) Asuka Inoue et al.   CELL

Crystal structure of the M5muscarinic acetylcholine receptor

(2019) Ziva Vuckovic et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

(2018) Michael J Curtis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Allosteric modulators targeting CNS muscarinic receptors

(2018) Andreas Bock et al.   NEUROPHARMACOLOGY

Muscarinic acetylcholine receptors: novel opportunities for drug development

(2014) Andrew C. Kruse et al.   NATURE REVIEWS DRUG DISCOVERY

Defining and characterizing drug/compound function

(2013) Terry Kenakin et al.   BIOCHEMICAL PHARMACOLOGY

Activation and allosteric modulation of a muscarinic acetylcholine receptor

(2013) Andrew C. Kruse et al.   NATURE

Signalling bias in new drug discovery: detection, quantification and therapeutic impact

(2013) Terry Kenakin et al.   NATURE REVIEWS DRUG DISCOVERY

Agonists with supraphysiological efficacy at the muscarinic M2ACh receptor

(2012) R Schrage et al.   BRITISH JOURNAL OF PHARMACOLOGY

Quantitative analysis of the loss of muscarinic receptors in various peripheral tissues in M1-M5 receptor single knockout mice

(2009) Yoshihiko Ito et al.   BRITISH JOURNAL OF PHARMACOLOGY

Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia

(2008) Anantha Shekhar et al.   AMERICAN JOURNAL OF PSYCHIATRY

Muscarinic acetylcholine receptors as CNS drug targets

(2007) Christopher J. Langmead et al.   PHARMACOLOGY & THERAPEUTICS